Abstract Background Artesunate-amodiaquine (AS+ AQ) and artemether-lumefantrine (AM-
L) are efficacious artemisinin combination therapy (ACT) regimens that have been widely …

Background Artemisinin-based combinations are recommended for treatment of
uncomplicated falciparum malaria, but are costly and in limited supply. Clindamycin plus …

Early parasite-based diagnosis of malaria prior to treatment is critical for rational drug use,
optimal outcome of febrile illness, patient adherence, prevention of parasite drug resistance …

Background This open-label, randomized study evaluated efficacy and safety of artemether-
lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) in treatment of uncomplicated …

In a prospective cross sectional study, the therapeutic efficacy of chloroquine was assessed
in children under the age of five years with uncomplicated P. falciparum malaria in Sokoto …

Background Benin has recently shifted its national antimalarial drug policy from
monotherapies to combinations containing artemisinin derivatives. When this decision was …

Plasmodium falciparum has developed resistance to almost all routinely used antimalarial
drugs. Sulfadoxine-pyrimethamine (SP) has replaced chloroquine as first-line treatment of …

Introduction Artemisinin-based combination therapy is currently the best option for the
treatment of uncomplicated malaria. Quinine is recommended as a rescue treatment. Safety …

Background Artemisinin-based combination therapy is currently recommended by the World
Health Organization as first-line treatment of uncomplicated malaria. Recommendations …

In late 2003, the efficacies of mefloquine monotherapy and of an artesunate–mefloquine
combination, for the oral treatment of uncomplicated, Plasmodium falciparum malaria, were …